Skip to main content

Animations

MJFF Publications

7761 - 7770 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2020
  • 2025
  • 2022
  • 2024
  • 2025
  • 2018
  • 2021
  • 2018
  • 2018
  • Summary Details
    OPEN
    Title: Benchmarking of a multi‐biomarker low‐volume panel for Alzheimer's disease and related dementia research
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14413
    Citation Count: 13
  • Summary Details
    RESTRICTED
    Title: Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy?
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2020.113357
    Citation Count: 18
  • Summary Details
    OPEN
    Title: N-type Ca2+ channels mediate the stimuli-dependent α-synuclein secretion in mouse striatum
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-01110-z
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Transmembrane protein ATG-9 links presynaptic autophagy with the synaptic vesicle cycle
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2022.2049151
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Biological Staging of the Parkinson’s Progression Markers Initiative (PPMI) Cohort Using the Research Neuronal α-synuclein Disease Integrated Staging System (NSD-ISS) (P11-3.009)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000204771
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Virtual Compound Screening for Discovery of Dopamine D1 Receptor Biased Allosteric Modulators
    Journal Name: Journal of Chemical Information and Modeling
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jcim.5c00972
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2018.00064
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease
    Journal Name: eneuro
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1523/eneuro.0559-20.2021
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-018-1947-3
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Subtype definition of vascular parkinsonism
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.03.005
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.